Friday, May 1, 2026

Coupang Data Breach: U.S. Investors Submit ISDS Arbitration Notice Against South Korea

Coupang faces international arbitration after a data breach, with U.S. investors alleging unfair treatment by South Korea's government.

SOCIALISM’S FINAL FAILURE: Defector Economist Reveals Kim’s Regime Can’t Stop The Capitalist TAKEOVER

North Korean economist Seol Song Ah explores local economies in her book, highlighting shifts towards marketization and self-reliance.

North Korea and Russia Are Ignoring Sanctions—And They’re Not Hiding It

North Korea and Russia's cooperation highlights sanctions violations, undermining international efforts to enforce restrictions on military and cultural exchanges.

Tag: precision medicine

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

GC Cell Showcases Cold Chain Innovations the Spring Symposium of the Korean Society of Laboratory Medicine

GC Cell, GC Green Cross, and GC Genome showcased innovations in diagnostics at the 2023 Spring Symposium, enhancing precision medicine.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

Transforming Healthcare: How Daewoong Pharmaceutical’s Digital Health Strategy Aims for 1 Trillion KRW in 5 Years

Daewoong Pharmaceutical's CEO Lee Chang-jae discusses shifting focus to predictive healthcare and aims for 1 trillion KRW in digital healthcare revenue.

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

3Billion Joins Global iHope Program for Rare Disease Diagnosis: A Game-Changer for Patients in Asia

3Billion becomes the first Asian partner in the iHope program, enhancing rare disease diagnostics for underserved pediatric patients globally.

K-Biohealth Surge: How AI and Precision Medicine are Transforming Global Markets in 2026

South Korean biohealth firms are expanding globally, showcasing AI solutions and forming partnerships at major healthcare events.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

Breakthrough Tech Tailors Gene Editing to Your DNA

Researchers at Pusan National University developed a tool for personalized gene editing, predicting side effects based on DNA variations.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.